UC health colleges collaborate to prepare future health care...
March 21, 2024
UC’s health colleges create SafeMovES Lab to teach nursing, physical and occupational therapy students how to safely care for patients.
March 21, 2024
UC’s health colleges create SafeMovES Lab to teach nursing, physical and occupational therapy students how to safely care for patients.
March 19, 2024
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
March 18, 2024
UC College of Medicine students celebrated Match Day on March 15, 2024.
March 21, 2024
UC’s health colleges create SafeMovES Lab to teach nursing, physical and occupational therapy students how to safely care for patients.
March 19, 2024
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
March 18, 2024
UC College of Medicine students celebrated Match Day on March 15, 2024.
March 18, 2024
WCPO highlighted the Steps for Stroke 2024 event, raising money to advance stroke research at the University of Cincinnati.
March 18, 2024
An international, multisite phase 3 trial co-led by a University of Cincinnati researcher found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
March 14, 2024
Jack Rubinstein, MD, is the chief medical officer launching TRPV Pharmaceuticals, a company dedicated to advancing a therapeutic approach for cardiovascular disease. Rubinstein is also a UC professor of internal medicine at the UC College of Medicine and a pioneering researcher in the field of cardiovascular diseases.
March 12, 2024
Hoxworth Blood Center Partners with Cincinnati Works to Enhance Employee Support and Foster Workplace Growth
March 8, 2024
Among patients with end-stage kidney disease (ESKD) on home dialysis, pregnancy rates are higher with home hemodialysis than peritoneal dialysis, according to new research from the University of Cincinnati.
March 7, 2024
A University of Cincinnati institute selected four new projects to tackle in its second year of helping high-tech industries address their most complicated problems. UC’s Industry 4.0/5.0 Institute is dedicated to harnessing UC’s collective talent across campuses to help solve pressing issues facing businesses.
March 6, 2024
The University of Cincinnati's Trisha Wise-Draper, MD, PhD, spoke with WDTN Dayton to discuss the approval of Amtagvi, the first cellular therapy for metastatic or unresectable melanoma, a harmful skin cancer.
March 6, 2024
University of Cincinnati Cancer Center researchers in the lab of Jun-Lin Guan, PhD, have identified a new protein that helps prevent metastasis of a subset called HER2-positive breast cancer.
March 4, 2024
The University of Cincinnati's Oluwole Awosika commented to Medscape on a new study that found a vibrating glove device could help manage hand spasticity symptoms after a stroke.
March 4, 2024
A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found the drug liraglutide was safe and effective for weight loss for patients with stable bipolar disorder.
March 1, 2024
President Neville G. Pinto invites the campus community to join the annual State of the University update on Monday, April 15, 2024. The address will be available both in-person and virtually.
February 29, 2024
Regional media highlighted the University of Cincinnati Cancer Center being the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer.